Mission Bio IPO

Mission Bio is the developer of the Tapestri Platform which is a single-cell multi-omics platform enabling genotype and phenotype from the same cell and precise detection of heterogeneity in disease progression and treatment response. This company was founded in 2014 by Adam Abate, Adam Sciambi, Charlie Silver and Dennis Eastburn and is headquartered in San Francisco, CA. Mission Bio helps researchers and clinicians unlock single-cell biology to enable the discovery, development, and delivery of precision medicine.

Register for Details

For more details on financing and valuation for Mission Bio, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Mission Bio's ticker symbol?

Mission Bio does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Mission Bio's stock price?

The stock price for Mission Bio will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Who are Mission Bio's major investors?

Mayfield Fund
Cota Capital
Novo Holdings
Agilent Technologies

Mission Bio Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
5/5/2022 Series D $369.43MM $XXX.XX $XXX.XX
8/13/2020 Series C $233.2MM $XXX.XX $XXX.XX
12/13/2018 Series B $77.88MM $XXX.XX $XXX.XX
10/17/2017 Series A $24.19MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Mission Bio

What is Mission Bio funding to date?

Mission Bio has raised $216.72MM with the following series:
$24.19MM for Series A, $77.88MM for Series B, $233.2MM for Series C, $369.43MM for Series D

When was Mission Bio founded?

Mission Bio was founded in 2014.

Can you invest in Mission Bio?

Mission Bio is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Mission Bio share pre-IPO?

If you own Mission Bio pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Is Mission Bio a publicly traded company?

Mission Bio is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Mission Bio in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$298.33MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$327.39MM
Sector